Human Genome Says Lupus Drug Promising
14th Nov 2006, 16:19 GMT
Biotech company Human Genome Sciences said its lupus treatment candidate lymphostat showed positive results in an extended midstage study.
Human Genome Says Lupus Drug Promising related news:
- Human Genome reports positive results on lupus drug — Pharmaceutical Business Review Latest News
- HGS reports positive Lupus drug test results — StratWire - Business of Healthcare NewsFeed
- Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus — PR Newswire: All Releases
- ZymoGenetics encouraged by early results on lupus treatment — bizjournals.com Health Care:Biotechnology headlines
- Technology's Promise: highlights from the TechCast project; An ongoing study of technology forecasts by leading experts shows promising breakthroughs in energy, information technology, health care, transportation, and other critical fields — KeepMedia: KeepMedia Home
- HHS: No H5N1 strain found in U.S. so far — FCW.com RSS Feeds
- Neurogen commences human testing of obesity drug — Pharmaceutical Business Review Latest News
- Mapping the mouse genome — EurekAlert! - Breaking News
- Study Says Lupus Drugs May Treat Atherosclerosis — RedOrbit News - Health
- Lupus Biomarkers Discovered — MedicineNet Arthritis General
Latest news from Operations-Related News from StratCenter.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies